WHO recommendations call for manufacturers to apply a continuous threat management course of action for sterility test isolators, which includes regular possibility assessments and the event of possibility-centered Handle tactics. Manufacturers aiming to put into practice these procedures should supply robust validation details to show their equivalence to pharmacopoeial waiting for link from Forum Profiles (6)